dacarbazine has been researched along with Neoplasms, Nervous System in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budach, W; Rapp, M; Sabel, M; Sadat, H; Slotty, PJ; Steiger, HJ | 1 |
Bigner, DD; Dolan, ME; Elion, GB; Friedman, HS; Houghton, PJ; Johnson, SP; Keir, S; Patel, VJ; Pegg, AE | 1 |
2 other study(ies) available for dacarbazine and Neoplasms, Nervous System
Article | Year |
---|---|
Feasibility of the EORTC/NCIC Trial Protocol in a Neurosurgical Outpatient Unit: The Case for Neurosurgical Neuro-Oncology.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Clinical Protocols; Cohort Studies; Combined Modality Therapy; Dacarbazine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Nervous System Neoplasms; Neurosurgery; Prospective Studies; Retrospective Studies; Survival Analysis; Temozolomide; Young Adult | 2015 |
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dacarbazine; Female; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nervous System Neoplasms; Temozolomide; Time Factors; Tumor Cells, Cultured | 2000 |